glp-1 analogs receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease GLP-1 Analogues Market Report, Growth

I have a new feature out in the New York Times Opinion today that I hope will change how people think about GLP-1 drugs, such as Ozempic or Mounjaro

Indeed, at their peak in 2024, nearly 1 in 3 Americans taking a GLP-1 drug said they were getting it from a compounding pharmacy

If power outages occur, keep the refrigerator door closed

Until this time, this experiment has provided the most thorough molecular exegesis of the clinical efficacy of semaglutide for patients with ischemic cardiomyopathy currently available

The obesity epidemic affecting our youth requires innovative approaches, and GLP-1 RAs may represent an important advancement in our therapeutic armamentarium

Coverage changes from state to state